AGI.do

Products

What will AGI do for Alcaftadine?

This classification denotes a histamine-1 receptor antagonist with the molecular formula C19H21N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7Z8O94ECSX. European Medicines Agency schedules alcaftadine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB37833. The term ALCAFTADINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 20, no. 3, 2006, list 56). Most nations schedule alcaftadine under HS 29333990 and SITC 51574. As of Q4 2014, ALCAFTADINE remains the US FDA Preferred Term for this commodity. Alcaftadine bears US NLM identifiers UMLS ID C2348241 and NCI Concept Code C72686. SMILES: CN1CCC(=C2C3=CC=CC=C3CCN4C2=NC=C4C=O)CC1.

How AGI delivers it

Four ways AGI delivers for Alcaftadine

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Alcaftadine, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Alcaftadine, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Alcaftadine connects

measured by

  • Active Ingredient Potencymodel
  • Compound Puritymodel
  • Particle Size Distributionmodel
  • Residual Solventmodel

Go deeper

Explore Alcaftadine

Read the deeper take on agi.asView as markdown